Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted CAGR for the Drugs for Immunotherapy Market Over the Forecast Period of 2025 to 2034?

The immunotherapy drugs market has seen a significant expansion in size over the past few years. The market, which is set to balloon from $255.14 billion in 2024 to $281.43 billion in 2025, is expected to see a compound annual growth rate (CAGR) of 10.3%. Factors such as an increased prevalence of cancer, uncatered medical requirements, heightened awareness about cancer immunotherapy, attractive adoption rates of immunotherapy techniques, and increased investments from major pharmaceutical entities have contributed to the surge in the growth rate registered in the past years.

The immunotherapy drugs market is projected to witness swift expansion in the ensuing years, escalating to a remarkable $445.12 billion by 2029, with a 12.1% Compound Annual Growth Rate (CAGR). This growth within the forecasted period could be credited to factors such as the proliferation of combination treatments, customization in medicine, worldwide expansion, biomarker-guided therapies, and a rise in clinical trials. The major impending trends include advancements in the realm of immunology, car-t cell therapies, targeted immunotherapies, combinations of immunotherapy, and the development of neoantigen vaccines.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the Drugs for Immunotherapy Market?

The market for immunotherapy drugs is propelled by an increasing number of cancer cases worldwide. A few of the most common cancer origins are obesity, smoking, alcohol consumption, and unhealthy eating. For example, Macmillan Cancer Support, the UK’s top health charity, estimates that by 2025 there will be 3.5 million cancer sufferers, 4 million by 2030, and 5.3 million by 2040. The most common types of cancers are those of the breast, lung, colon, rectum, and prostate. About one third of cancer deaths can be attributed to the use of tobacco, high body mass index, alcohol consumption, a diet low in fruits and vegetables, and a lack of exercise. It’s predicted that as cancer cases continue to rise, so will the demand for immunotherapy drugs, subsequently giving a boost to the growth of the immunotherapy drugs market.

Request Your Free Drugs for Immunotherapy Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp

Who Are the Top Companies Driving Innovation and Growth in the Drugs for Immunotherapy Market?

Major companies operating in the drugs for immunotherapy market include F. Hoffmann-La Roche Ltd., Novartis AG, Amgen Inc., AbbVie Inc., Merck & Co. Inc., GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, Johnson & Johnson, UbiVac, Pfizer Inc., Sanofi SA, Bayer AG, Celgene Corporation, Incyte Corporation, Juno Therapeutics Inc., Bluebird bio, Celldex Therapeutics, BeiGene, BioNTech AG, CytomX Therapeutics, Eisai Co. Ltd., Flexus Biosciences Inc., Genscript Biotech Corporation, Gilead Sciences Inc., Harpoon Therapeutics Inc., Heptares Therapeutics Ltd., Ignyta Inc., Immatics Biotechnologies, Jounce Therapeutics Inc.

What Are the Latest Innovations and Trends Influencing the Drugs for Immunotherapy Market?

Major corporations in the immunotherapy drugs market are concentrating their efforts on developing new products like Keytruda (pembrolizumab) to better serve their clients. Keytruda (pembrolizumab) is a unique form of immunotherapy that uses an immune checkpoint inhibitor medication designed for adult patients. For example, Merck & Co., Inc., a pharmaceutical company based in the US, introduced Keytruda (pembrolizumab) in January 2023. This product, which was sanctioned by the US-based federal agency, the Food and Drug Administration, is used in the treatment of various cancers by collaborating with the immune system to battle cancer cells. As an adjuvant therapy for non-small cell lung cancer (NSCLC), KEYTRUDA (pembrolizumab) has been approved. This advancement in cancer care is significant and is predicted to positively influence the healthcare industry.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Which Key Segments Define the Structure of the Drugs for Immunotherapy Market and Their Growth Potential?

The drugs for immunotherapy market covered in this report is segmented –

1) By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types

2) By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas

3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies

2) By Interferons: Interferon Alfa, Interferon Beta, Interferon Gamma

3) By Interleukins: Interleukin-2 (IL-2), Interleukin-6 (IL-6), Interleukin-12 (IL-12)

4) By Vaccines: Preventive Vaccines, Therapeutic Vaccines

5) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

6) By Other Types: Cancer Cell Therapies, Cytokine Therapy, T-Cell Receptor Therapy

Which Geographical Regions Are Pioneering Growth in the Drugs for Immunotherapy Market?

The countries covered in the drugs for immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Are the Defining Aspects of the Drugs for Immunotherapy Market Landscape?

Drugs for immunotherapy refer to a kind of medication that offers treatment to either stimulate or suppress the immune system to aid the body’s protection against cancer, infection, and other disorders. Your immune system is assisted in fighting cancer via immunotherapy, a sort of cancer treatment. The body’s immune system aids in the fight against infections and other disorders.

Browse Through More Similar Reports By The Business Research Company:

Cellular Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Immunofluorescence Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: